CDH2 and lung carcinoma: Lung cancer cells fused with MSCs undergo EMT, characterized by downregulation of E-cadherin and pancytokeratin expression and gain of N-cadherin, Vimentin, αSMA, and fibronectin expression, and increased EMT transcription factors Snail1, Slug, Twist1, Zeb1, and Zeb2, and acquisition of stem cell properties [317,318].